| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 30 | 2024 | 536 | 9.560 |
Why?
|
| Hematopoiesis | 17 | 2024 | 218 | 5.800 |
Why?
|
| Hematologic Diseases | 4 | 2024 | 75 | 2.380 |
Why?
|
| Interferon-gamma | 6 | 2024 | 506 | 2.100 |
Why?
|
| Cell Differentiation | 10 | 2024 | 1923 | 1.560 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 3 | 2022 | 125 | 1.520 |
Why?
|
| Bone Marrow | 7 | 2022 | 317 | 1.500 |
Why?
|
| Antigens, CD | 2 | 2024 | 424 | 1.450 |
Why?
|
| Gastrointestinal Microbiome | 4 | 2024 | 654 | 1.410 |
Why?
|
| Interferon Type I | 2 | 2022 | 105 | 1.240 |
Why?
|
| Interferon-alpha | 4 | 2018 | 218 | 1.120 |
Why?
|
| GPI-Linked Proteins | 2 | 2024 | 95 | 1.110 |
Why?
|
| Bone Marrow Cells | 5 | 2021 | 259 | 1.060 |
Why?
|
| Inflammation | 6 | 2024 | 1392 | 1.040 |
Why?
|
| Bone Marrow Diseases | 2 | 2022 | 37 | 0.950 |
Why?
|
| Mice | 28 | 2024 | 17406 | 0.950 |
Why?
|
| Animals | 37 | 2024 | 33423 | 0.950 |
Why?
|
| Cell Proliferation | 8 | 2018 | 2307 | 0.910 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2023 | 9 | 0.880 |
Why?
|
| Anemia | 2 | 2017 | 337 | 0.850 |
Why?
|
| Mice, Knockout | 7 | 2024 | 3760 | 0.850 |
Why?
|
| Anti-Bacterial Agents | 7 | 2021 | 2372 | 0.840 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 317 | 0.840 |
Why?
|
| Interferons | 2 | 2021 | 118 | 0.800 |
Why?
|
| Immunomodulation | 1 | 2022 | 79 | 0.770 |
Why?
|
| Signal Transduction | 12 | 2022 | 4499 | 0.740 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 2020 | 10 | 0.740 |
Why?
|
| Stem Cells | 2 | 2024 | 704 | 0.730 |
Why?
|
| Busulfan | 1 | 2020 | 44 | 0.720 |
Why?
|
| Streptococcal Infections | 3 | 2022 | 240 | 0.720 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2020 | 28 | 0.720 |
Why?
|
| GTP-Binding Proteins | 2 | 2011 | 176 | 0.710 |
Why?
|
| Clonal Evolution | 1 | 2019 | 38 | 0.680 |
Why?
|
| Immunologic Factors | 1 | 2021 | 175 | 0.670 |
Why?
|
| Thrombocythemia, Essential | 2 | 2018 | 27 | 0.650 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 212 | 0.650 |
Why?
|
| Polycythemia Vera | 2 | 2018 | 37 | 0.640 |
Why?
|
| STAT1 Transcription Factor | 2 | 2016 | 67 | 0.630 |
Why?
|
| Dysbiosis | 2 | 2024 | 115 | 0.620 |
Why?
|
| Hydroxyurea | 2 | 2018 | 82 | 0.620 |
Why?
|
| Membrane Glycoproteins | 1 | 2020 | 411 | 0.620 |
Why?
|
| Mice, Inbred C57BL | 11 | 2024 | 4327 | 0.620 |
Why?
|
| Neoplasms | 2 | 2023 | 2743 | 0.620 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 7 | 2024 | 1168 | 0.610 |
Why?
|
| Bromodeoxyuridine | 1 | 2018 | 60 | 0.600 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2017 | 8 | 0.590 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2017 | 9 | 0.590 |
Why?
|
| Erythroid Precursor Cells | 1 | 2017 | 24 | 0.590 |
Why?
|
| Environmental Exposure | 1 | 2019 | 211 | 0.590 |
Why?
|
| Histamine | 1 | 2017 | 44 | 0.590 |
Why?
|
| Abscess | 1 | 2019 | 138 | 0.590 |
Why?
|
| Erythropoiesis | 1 | 2017 | 40 | 0.580 |
Why?
|
| Flow Cytometry | 2 | 2018 | 814 | 0.580 |
Why?
|
| Sepsis | 1 | 2022 | 471 | 0.580 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2016 | 18 | 0.560 |
Why?
|
| Microbiota | 1 | 2022 | 390 | 0.560 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2022 | 785 | 0.550 |
Why?
|
| Thrombocytosis | 1 | 2016 | 34 | 0.550 |
Why?
|
| Leukopenia | 1 | 2016 | 44 | 0.540 |
Why?
|
| Cytokines | 7 | 2022 | 1272 | 0.540 |
Why?
|
| Osteomyelitis | 1 | 2019 | 199 | 0.530 |
Why?
|
| Stress, Physiological | 1 | 2017 | 264 | 0.500 |
Why?
|
| Epigenesis, Genetic | 3 | 2024 | 657 | 0.490 |
Why?
|
| Cat-Scratch Disease | 1 | 2015 | 34 | 0.490 |
Why?
|
| Disease Management | 1 | 2019 | 512 | 0.490 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 99 | 0.480 |
Why?
|
| Mutation | 8 | 2023 | 5737 | 0.480 |
Why?
|
| Epithelium | 1 | 2015 | 371 | 0.450 |
Why?
|
| Candidiasis | 2 | 2019 | 128 | 0.450 |
Why?
|
| Humans | 35 | 2024 | 121122 | 0.420 |
Why?
|
| Graft vs Host Disease | 3 | 2024 | 517 | 0.400 |
Why?
|
| Virus Diseases | 1 | 2015 | 262 | 0.400 |
Why?
|
| Receptors, Interferon | 1 | 2011 | 25 | 0.380 |
Why?
|
| Alchemy | 1 | 2011 | 3 | 0.380 |
Why?
|
| Dermis | 1 | 2011 | 24 | 0.370 |
Why?
|
| Cell Lineage | 4 | 2020 | 347 | 0.370 |
Why?
|
| Science | 1 | 2011 | 32 | 0.360 |
Why?
|
| MicroRNAs | 1 | 2017 | 835 | 0.360 |
Why?
|
| Immunity | 1 | 2011 | 182 | 0.360 |
Why?
|
| Epithelial Cells | 1 | 2015 | 897 | 0.350 |
Why?
|
| Homeostasis | 4 | 2018 | 680 | 0.350 |
Why?
|
| Leprostatic Agents | 1 | 2009 | 2 | 0.330 |
Why?
|
| Leprosy | 1 | 2009 | 19 | 0.330 |
Why?
|
| Lipopeptides | 1 | 2009 | 33 | 0.330 |
Why?
|
| Adoption | 1 | 2009 | 16 | 0.330 |
Why?
|
| Fungemia | 1 | 2009 | 22 | 0.330 |
Why?
|
| Echinocandins | 1 | 2009 | 44 | 0.320 |
Why?
|
| Cell Cycle | 4 | 2018 | 617 | 0.320 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2009 | 138 | 0.310 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2009 | 104 | 0.300 |
Why?
|
| Cell Division | 2 | 2020 | 796 | 0.290 |
Why?
|
| Streptococcus pyogenes | 3 | 2005 | 74 | 0.290 |
Why?
|
| Tuberculosis | 2 | 2011 | 566 | 0.290 |
Why?
|
| Hematologic Neoplasms | 2 | 2021 | 267 | 0.280 |
Why?
|
| Infant, Premature, Diseases | 1 | 2009 | 237 | 0.280 |
Why?
|
| Antifungal Agents | 1 | 2009 | 292 | 0.270 |
Why?
|
| Fibroblasts | 1 | 2011 | 874 | 0.270 |
Why?
|
| Myeloid Cells | 2 | 2017 | 99 | 0.260 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2023 | 525 | 0.250 |
Why?
|
| Janus Kinase 2 | 2 | 2018 | 133 | 0.250 |
Why?
|
| Bone Marrow Stromal Antigen 2 | 1 | 2024 | 5 | 0.240 |
Why?
|
| Disease Models, Animal | 6 | 2024 | 4246 | 0.240 |
Why?
|
| Glutathione Peroxidase | 2 | 2004 | 32 | 0.240 |
Why?
|
| Bacteroides | 1 | 2024 | 32 | 0.230 |
Why?
|
| Membrane Microdomains | 1 | 2024 | 60 | 0.230 |
Why?
|
| Clone Cells | 2 | 2022 | 166 | 0.230 |
Why?
|
| Interleukin-1alpha | 1 | 2023 | 8 | 0.220 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2023 | 26 | 0.220 |
Why?
|
| Cigarette Smoking | 1 | 2023 | 56 | 0.210 |
Why?
|
| Female | 12 | 2024 | 64043 | 0.200 |
Why?
|
| Peroxidases | 2 | 2005 | 26 | 0.200 |
Why?
|
| Streptococcus | 1 | 2022 | 61 | 0.200 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 2577 | 0.200 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 1673 | 0.190 |
Why?
|
| Mice, SCID | 1 | 2022 | 571 | 0.190 |
Why?
|
| Immunity, Innate | 1 | 2024 | 370 | 0.190 |
Why?
|
| Gene Expression | 3 | 2016 | 1577 | 0.190 |
Why?
|
| E-Selectin | 1 | 2020 | 42 | 0.190 |
Why?
|
| Radiation Chimera | 1 | 2020 | 14 | 0.180 |
Why?
|
| Chemokine CXCL12 | 1 | 2020 | 33 | 0.180 |
Why?
|
| Interleukin-6 | 1 | 2022 | 396 | 0.180 |
Why?
|
| Inhalation Exposure | 1 | 2020 | 34 | 0.180 |
Why?
|
| Smoke | 1 | 2020 | 47 | 0.180 |
Why?
|
| Intestines | 1 | 2024 | 572 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 3066 | 0.180 |
Why?
|
| Fluorouracil | 1 | 2020 | 142 | 0.180 |
Why?
|
| Hydrogen Peroxide | 1 | 2000 | 111 | 0.180 |
Why?
|
| Tobacco Products | 1 | 2020 | 62 | 0.180 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 1677 | 0.170 |
Why?
|
| Toll-Like Receptors | 2 | 2018 | 83 | 0.170 |
Why?
|
| Stem Cell Transplantation | 1 | 2022 | 237 | 0.170 |
Why?
|
| Myeloproliferative Disorders | 1 | 2021 | 85 | 0.170 |
Why?
|
| Thyroid Crisis | 1 | 2019 | 5 | 0.170 |
Why?
|
| Thyroiditis, Suppurative | 1 | 2019 | 5 | 0.170 |
Why?
|
| Repressor Proteins | 2 | 2005 | 810 | 0.170 |
Why?
|
| Protein Phosphatase 2C | 1 | 2019 | 55 | 0.170 |
Why?
|
| Candida tropicalis | 1 | 2019 | 16 | 0.170 |
Why?
|
| Bacterial Proteins | 2 | 2005 | 869 | 0.170 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 544 | 0.170 |
Why?
|
| Mycobacterium avium | 2 | 2016 | 15 | 0.160 |
Why?
|
| Male | 9 | 2024 | 58941 | 0.160 |
Why?
|
| Nod1 Signaling Adaptor Protein | 1 | 2018 | 2 | 0.160 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 139 | 0.160 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2018 | 50 | 0.160 |
Why?
|
| Models, Immunological | 1 | 2018 | 35 | 0.160 |
Why?
|
| Nutrition Disorders | 1 | 2018 | 32 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2023 | 504 | 0.150 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2018 | 79 | 0.150 |
Why?
|
| Cell Self Renewal | 1 | 2016 | 40 | 0.140 |
Why?
|
| Granulocytes | 1 | 2016 | 65 | 0.140 |
Why?
|
| Germ-Free Life | 1 | 2016 | 60 | 0.140 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 216 | 0.140 |
Why?
|
| DNA Damage | 1 | 2019 | 514 | 0.140 |
Why?
|
| Neutropenia | 1 | 2018 | 203 | 0.140 |
Why?
|
| West Nile Fever | 1 | 2018 | 127 | 0.130 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2016 | 92 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 559 | 0.130 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2016 | 14 | 0.130 |
Why?
|
| Graft Survival | 1 | 2018 | 520 | 0.130 |
Why?
|
| Apoptosis | 1 | 2022 | 1788 | 0.130 |
Why?
|
| Immunocompromised Host | 1 | 2018 | 298 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2016 | 53 | 0.130 |
Why?
|
| GATA2 Transcription Factor | 1 | 2016 | 45 | 0.130 |
Why?
|
| Anemia, Aplastic | 1 | 2016 | 53 | 0.130 |
Why?
|
| Zinc Fingers | 1 | 2016 | 111 | 0.130 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2015 | 16 | 0.130 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 137 | 0.130 |
Why?
|
| Methanococcus | 1 | 1995 | 2 | 0.120 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 2439 | 0.120 |
Why?
|
| Societies, Scientific | 1 | 2014 | 25 | 0.120 |
Why?
|
| Immunophenotyping | 2 | 2016 | 333 | 0.120 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2014 | 54 | 0.120 |
Why?
|
| Stem Cell Niche | 1 | 2014 | 52 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2005 | 2586 | 0.120 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2014 | 16 | 0.120 |
Why?
|
| Hematology | 1 | 2014 | 36 | 0.120 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2014 | 31 | 0.120 |
Why?
|
| Genes, Bacterial | 1 | 1995 | 207 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2015 | 333 | 0.110 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2018 | 306 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 397 | 0.110 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 515 | 0.110 |
Why?
|
| Sequence Deletion | 1 | 2016 | 526 | 0.110 |
Why?
|
| Protein Kinases | 1 | 1995 | 329 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 207 | 0.110 |
Why?
|
| Antiviral Agents | 1 | 2018 | 724 | 0.110 |
Why?
|
| Macrophages | 1 | 2016 | 613 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 803 | 0.100 |
Why?
|
| Receptors, Cytokine | 1 | 2011 | 57 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 429 | 0.100 |
Why?
|
| Bone Marrow Transplantation | 2 | 2011 | 577 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 2038 | 0.090 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 71 | 0.090 |
Why?
|
| Texas | 1 | 2019 | 3515 | 0.090 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 281 | 0.090 |
Why?
|
| Infant | 2 | 2019 | 12219 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 285 | 0.080 |
Why?
|
| Ethiopia | 1 | 2009 | 20 | 0.080 |
Why?
|
| Aspartate Aminotransferases | 1 | 2009 | 75 | 0.080 |
Why?
|
| Liver Function Tests | 1 | 2009 | 102 | 0.080 |
Why?
|
| Genetic Markers | 1 | 2011 | 598 | 0.080 |
Why?
|
| Amphotericin B | 1 | 2009 | 90 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2011 | 738 | 0.080 |
Why?
|
| Alanine Transaminase | 1 | 2009 | 149 | 0.080 |
Why?
|
| Prednisone | 1 | 2009 | 272 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1292 | 0.080 |
Why?
|
| Risk Factors | 1 | 2022 | 9617 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 999 | 0.080 |
Why?
|
| Regeneration | 2 | 2024 | 200 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 922 | 0.070 |
Why?
|
| Autophagy | 1 | 2011 | 391 | 0.070 |
Why?
|
| Crohn Disease | 1 | 2011 | 280 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 1708 | 0.070 |
Why?
|
| Cholestasis | 1 | 2009 | 160 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 278 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2019 | 11690 | 0.070 |
Why?
|
| Child | 3 | 2019 | 23984 | 0.070 |
Why?
|
| Adult | 2 | 2024 | 28389 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2005 | 3855 | 0.070 |
Why?
|
| Alleles | 1 | 2011 | 1587 | 0.070 |
Why?
|
| Aged | 3 | 2022 | 18432 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 1138 | 0.060 |
Why?
|
| Time Factors | 1 | 2015 | 5976 | 0.060 |
Why?
|
| Regulon | 1 | 2005 | 10 | 0.060 |
Why?
|
| Peroxides | 1 | 2005 | 12 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1674 | 0.060 |
Why?
|
| Peroxiredoxins | 2 | 2005 | 9 | 0.060 |
Why?
|
| Amino Acid Sequence | 3 | 2000 | 2668 | 0.060 |
Why?
|
| Bacteroides thetaiotaomicron | 1 | 2024 | 7 | 0.060 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2023 | 20 | 0.060 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2005 | 153 | 0.060 |
Why?
|
| Genomic Imprinting | 1 | 2024 | 123 | 0.060 |
Why?
|
| Achievement | 1 | 2023 | 32 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2019 | 13733 | 0.050 |
Why?
|
| Research Personnel | 1 | 2023 | 117 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2024 | 966 | 0.050 |
Why?
|
| DNA Modification Methylases | 1 | 2022 | 43 | 0.050 |
Why?
|
| Aging | 2 | 2022 | 1154 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2024 | 286 | 0.050 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2005 | 358 | 0.050 |
Why?
|
| Organoids | 1 | 2024 | 275 | 0.050 |
Why?
|
| Middle Aged | 2 | 2024 | 25297 | 0.050 |
Why?
|
| Adolescent | 2 | 2019 | 18761 | 0.050 |
Why?
|
| Feces | 1 | 2024 | 688 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2019 | 15593 | 0.050 |
Why?
|
| Aerobiosis | 1 | 2000 | 14 | 0.050 |
Why?
|
| Paraquat | 1 | 2000 | 12 | 0.050 |
Why?
|
| Drug Resistance, Microbial | 1 | 2000 | 192 | 0.040 |
Why?
|
| Genome, Bacterial | 1 | 2000 | 184 | 0.040 |
Why?
|
| Pulmonary Emphysema | 1 | 2020 | 93 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2000 | 350 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2019 | 46 | 0.040 |
Why?
|
| Ethanol | 1 | 2000 | 160 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 127 | 0.040 |
Why?
|
| Thyroidectomy | 1 | 2019 | 101 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2021 | 332 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2021 | 630 | 0.040 |
Why?
|
| Prognosis | 2 | 2018 | 4473 | 0.040 |
Why?
|
| Phenotype | 2 | 2012 | 4194 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2018 | 348 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 1995 | 292 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2022 | 1022 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 672 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 469 | 0.030 |
Why?
|
| Sequence Alignment | 2 | 1995 | 613 | 0.030 |
Why?
|
| Decalcification, Pathologic | 1 | 2016 | 1 | 0.030 |
Why?
|
| Side-Population Cells | 1 | 2016 | 10 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 1076 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 2538 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2009 | 7975 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 238 | 0.030 |
Why?
|
| Eukaryotic Cells | 1 | 1995 | 31 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 234 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2016 | 383 | 0.030 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1995 | 73 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 1363 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 1995 | 211 | 0.030 |
Why?
|
| Immune System | 1 | 2014 | 86 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 238 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2016 | 706 | 0.030 |
Why?
|
| Multigene Family | 1 | 1995 | 299 | 0.030 |
Why?
|
| Virulence | 2 | 2005 | 239 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2016 | 262 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 162 | 0.030 |
Why?
|
| Genomics | 1 | 2021 | 1473 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2014 | 297 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 296 | 0.030 |
Why?
|
| Leukemia | 1 | 2014 | 377 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2014 | 521 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 864 | 0.020 |
Why?
|
| Multipotent Stem Cells | 1 | 2010 | 29 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 996 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 249 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 2530 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 3067 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 2917 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 1143 | 0.020 |
Why?
|
| DNA Footprinting | 1 | 2005 | 14 | 0.020 |
Why?
|
| Oxidants | 1 | 2005 | 25 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2005 | 478 | 0.010 |
Why?
|
| Zebrafish | 1 | 2004 | 370 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 1357 | 0.010 |
Why?
|
| Skin | 1 | 2004 | 499 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 1733 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 3104 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2005 | 787 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 2780 | 0.010 |
Why?
|
| Glucokinase | 1 | 1995 | 16 | 0.010 |
Why?
|
| Glycerol Kinase | 1 | 1995 | 19 | 0.010 |
Why?
|
| Genes, Helminth | 1 | 1995 | 20 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1995 | 33 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 651 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 1995 | 221 | 0.010 |
Why?
|
| Phylogeny | 1 | 1995 | 674 | 0.010 |
Why?
|
| Software | 1 | 1995 | 669 | 0.010 |
Why?
|
| Databases, Factual | 1 | 1995 | 1139 | 0.010 |
Why?
|